Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
China flag China · Delayed Price · Currency is CNY
7.82
+0.05 (0.64%)
Apr 30, 2026, 3:04 PM CST

SHE:300636 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
73.09106.58105.98100.6781.12
Depreciation & Amortization
131.17114.5869.3966.8851.58
Other Amortization
0.510.19---
Loss (Gain) From Sale of Assets
0.771.171.320.181.01
Asset Writedown & Restructuring Costs
61.98----0.04
Loss (Gain) From Sale of Investments
1.12-0.62-0.571.21-0.28
Provision & Write-off of Bad Debts
-1.27-0.111.482.11
Other Operating Activities
13.8839.7822.961510.48
Change in Accounts Receivable
-37.2-12.4922.41-11.52-61.27
Change in Inventory
-20.13-55.66-45.2-131.24-42.8
Change in Accounts Payable
31.45100.72-23.01133.0185.34
Change in Other Net Operating Assets
-56.83-16.34.3314.85-3.12
Operating Cash Flow
202.07285.19163.75196131.34
Operating Cash Flow Growth
-29.14%74.16%-16.45%49.23%64.04%
Capital Expenditures
-291.24-136.49-214.65-311.49-424.67
Sale of Property, Plant & Equipment
0.390.490.231.120.44
Investment in Securities
273.57-370.33-493.96-30-20
Other Investing Activities
0.370.682.18-1.610.02
Investing Cash Flow
-16.91-505.65-706.21-341.99-444.21
Long-Term Debt Issued
459.89870.49924.7391.74427.46
Long-Term Debt Repaid
-525.62-937.36-770.72-285.68-211.16
Net Debt Issued (Repaid)
-65.73-66.87153.98106.06216.3
Issuance of Common Stock
--789.8241.42-
Repurchase of Common Stock
--12.98-0.43--
Common Dividends Paid
-28.78-29.12-26.91-32.11-21.8
Other Financing Activities
-3.46-238.8-46.8-6.82
Financing Cash Flow
-97.96-110.97955.2668.57187.68
Foreign Exchange Rate Adjustments
0.234.051.821.13-0.74
Net Cash Flow
87.43-327.39414.62-76.29-125.93
Free Cash Flow
-89.17148.7-50.9-115.5-293.33
Free Cash Flow Margin
-10.76%19.59%-7.05%-16.04%-49.54%
Free Cash Flow Per Share
-0.210.35-0.13-0.33-0.87
Cash Income Tax Paid
-46.55-27.75-41.2-84.82-59.22
Levered Free Cash Flow
-574.221-201.9-197.59-293.72
Unlevered Free Cash Flow
-574.232.34-195.72-192.78-290.16
Change in Working Capital
-80.4422.24-35.2310.57-14.64
Source: S&P Global Market Intelligence. Standard template. Financial Sources.